Injectable contraception with depot medroxyprogesterone acetate. Current status.
Kaunitz
Andrew M
AM
Department of Obstetrics and Gynecology, University of Florida Health Science Center, 653 West 8th Street, Jacksonville, Florida, 32209, USA.
Rosenfield
Allan
A
Columbia School of Public Health, and Department of Obstetrics and Gynecology, Columbia Presbyterian Medical Center, New York, New York, USA.
D000328:Adult; D015519:Bone Density / Q000187:drug effects; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005260:Female; D005833:Genital Neoplasms, Female / Q000139:chemically induced; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects; D008598:Menstruation / Q000187:drug effects; D008875:Middle Aged; D012098:Reproduction / Q000187:drug effects; D012307:Risk Factors
D003276:Contraceptives, Oral; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate